NEW YORK (GenomeWeb) – A group led by Mount Sinai researchers have developed a DNA- and RNA-based sequencing computational method to identify genetic mutations in patients with relapsed multiple myeloma and potentially tailor treatments based on tumor susceptibility to certain drugs.
Get the full story with
GenomeWeb Premium Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.